Search

everythinglearnresearchcommunity

for

Search:↓

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain drugs that block specific enzymes can help treat prostate diseases.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

PCOS may increase the risk of certain cancers.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

FDG PET/CT scans can change cancer treatment plans for dogs.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.